Healthcare provider profile · identity verified

Amanda Mae Olson, D.O.

Internal Medicine · PHILIPSBURG, PA · NPI 1609018274

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	722	207
Amlodipine Besylate	Amlodipine Besylate	367	100
Lisinopril	Lisinopril	361	102
Levothyroxine Sodium	Levothyroxine Sodium	357	98
Losartan Potassium	Losartan Potassium	334	87
Omeprazole	Omeprazole	325	102
Metoprolol Succinate	Metoprolol Succinate	271	69
Pantoprazole Sodium	Pantoprazole Sodium	191	50
Furosemide	Furosemide	190	54
Hydrochlorothiazide	Hydrochlorothiazide	183	51
Sertraline Hcl	Sertraline Hcl	177	45
Rosuvastatin Calcium	Rosuvastatin Calcium	156	53
Metoprolol Tartrate	Metoprolol Tartrate	151	39
Gabapentin	Gabapentin	148	43
Metformin Hcl	Metformin Hcl	145	47
Jardiance	Empagliflozin	142	37
Ozempic	Semaglutide	134	26
Duloxetine Hcl	Duloxetine Hcl	123	30
Metformin Hcl Er	Metformin Hcl	122	33
Citalopram Hbr	Citalopram Hydrobromide	116	31
Eliquis	Apixaban	111	26
Lorazepam	Lorazepam	109	32
Albuterol Sulfate Hfa	Albuterol Sulfate	107	48
Atenolol	Atenolol	104	26
Allopurinol	Allopurinol	100	30
Alendronate Sodium	Alendronate Sodium	95	30
Trulicity	Dulaglutide	95	16
Simvastatin	Simvastatin	91	24
Buspirone Hcl	Buspirone Hcl	88	26
Tamsulosin Hcl	Tamsulosin Hcl	85	30
Glipizide Er	Glipizide	79	24
Potassium Chloride	Potassium Chloride	73	26
Famotidine	Famotidine	70	19
Carvedilol	Carvedilol	69	24
Tramadol Hcl	Tramadol Hcl	67	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	19
Warfarin Sodium	Warfarin Sodium	67	22
Montelukast Sodium	Montelukast Sodium	65	20
Escitalopram Oxalate	Escitalopram Oxalate	62	13
Ezetimibe	Ezetimibe	62	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	13
Finasteride	Finasteride	57	15
Alprazolam	Alprazolam	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	22
Pregabalin	Pregabalin	45	suppressed
Spironolactone	Spironolactone	44	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	16
Novolog Flexpen	Insulin Aspart	42	suppressed
Trazodone Hcl	Trazodone Hcl	42	16
Clopidogrel	Clopidogrel Bisulfate	39	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Prednisone	Prednisone	39	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Lovastatin	Lovastatin	36	suppressed
Synthroid	Levothyroxine Sodium	36	suppressed
Fenofibrate	Fenofibrate,micronized	34	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	31	suppressed
Amoxicillin	Amoxicillin	30	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	11
Nitroglycerin	Nitroglycerin	26	19
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	16
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Torsemide	Torsemide	24	suppressed
Cephalexin	Cephalexin	22	14
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fluconazole	Fluconazole	20	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Nystatin	Nystatin	20	13
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	19	19
Celecoxib	Celecoxib	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Azithromycin	Azithromycin	18	17
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Carbamazepine	Carbamazepine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	11
Temazepam	Temazepam	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lactulose	Lactulose	13	suppressed
Risperidone	Risperidone	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Valsartan	Valsartan	13	suppressed
Digoxin	Digoxin	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error